Target intelligence / Profile preview

PRICKLE2 antisense RNA 3 (PRICKLE2-AS3)

Target
PRICKLE2-AS3
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

PRICKLE2 antisense RNA 3 (PRICKLE2-AS3) is a long non-coding RNA (lncRNA) gene located on chromosome 3 in humans[4][5][6]. It does not code for a protein but may play a role in the regulation of gene expression, particularly during developmental processes[6]. As of the current knowledge and published data, PRICKLE2-AS3 is not considered a therapeutic target, nor is it classified as a receptor, enzyme, transporter, or other druggable protein class. Most research focuses on its basic biology, such as possible involvement in gene regulation related to neurodevelopment, but its direct biological functions, disease associations, drug interactions, mechanisms of action, biomarker utility, or safety concerns have not been established or reported in the scientific literature[5][6]. No evidence indicates that PRICKLE2-AS3 is involved in neurodevelopmental or neurodegenerative diseases, in contrast to the protein-coding gene PRICKLE2, which is implicated in autism spectrum disorder, epilepsy, and Alzheimer's disease[1][3][7]. PRICKLE2-AS3 should also not be confused with PRICKLE2, a protein-coding gene with established neurological functions and disease associations.

Other names
PRICKLE2-AS3PRICKLE2 antisense RNA 3 (non-protein coding)
02

Biological functions

Regulation of gene expression
03

Disease associations

None definitively established; research is ongoing

Beyond the preview

Go deeper on PRICKLE2 antisense RNA 3 (PRICKLE2-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRICKLE2 antisense RNA 3 (PRICKLE2-AS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call